Tobramycin
Tobramycin is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Tobramycin; Generic name: TOBRAMYCIN; Drug class: Aminoglycoside Antibacterial [EPC].
| Brand name | Tobramycin |
|---|---|
| Generic name | TOBRAMYCIN |
| Drug class | Aminoglycoside Antibacterial [EPC] |
| Manufacturer | Amneal Pharmaceuticals LLC |
| Used for | 1 INDICATIONS AND USAGE Tobramycin inhalation solution is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa . Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with forced expiratory volume in 1 second (FEV 1 ) < 25% or > 75% predicted, or patients colonized with Burkholderia cepacia [see Clinical Studies (14) ]. Tobramycin is an aminoglycoside antibacterial indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa . ( 1 ) Safety and efficacy have not been demonstrated in patients under the |
| Dosage | 2 DOSAGE AND ADMINISTRATION For oral inhalation only. ( 2.1 ) The recommended dosage for adults and pediatric patients 6 years of age and older is one single-dose ampule (300 mg) twice daily by oral inhalation in alternating periods of 28 days on drug, followed by 28 days off drug. ( 2.1 ) Dosage is not adjusted by weight. ( 2.1 ) Take doses as close to 12 hours apart as possible; but not less than 6 hours apart. ( 2.1 ) Administer each 300 mg dose by inhalation using a hand-held PARI LC PLUS Re |
| Active ingredient(s) | TOBRAMYCIN |
| Route | RESPIRATORY (INHALATION) |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=15f9c0cd-7dbf-4a91-9961-14f1dd000343 |